SCHEMBL7370841

SCHEMBL7370841

Cc1c(C(Cc2ccc3cncnc3c2)N2CCNCC2=O)sc2c1C(C)(N)CS2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374157 0.71 F10 (0.32)
SCHEMBL7407923 0.71 EGFR (0.36)
SCHEMBL7409252 0.69 F10 (0.32)
SCHEMBL7375611 0.68 CDK2 (0.31)
SCHEMBL7407384 0.68 P2RX7 (0.33)
SCHEMBL7369284 0.67 F10 (0.45)
SCHEMBL7376327 0.67 F10 (0.39)
SCHEMBL7370835 0.66 F10 (0.35)
SCHEMBL7554775 0.62 F10 (0.38)
SCHEMBL7409241 0.62 F10 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051176-A4 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARM PROD INC (US) 2002-06-12 EP disclosed
EP-1051176-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS Aventis Pharmaceuticals Products Inc. (US) 2000-11-15 EP disclosed
WO-1999037304-A1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-07-29 WO disclosed